These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30536468)

  • 21. Cost-effectiveness of antibiotic treatment strategies for community-acquired pneumonia: results from a cluster randomized cross-over trial.
    van Werkhoven CH; Postma DF; Mangen MJ; Oosterheert JJ; Bonten MJ;
    BMC Infect Dis; 2017 Jan; 17(1):52. PubMed ID: 28068956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dilemma of monotherapy or combination therapy in community-acquired pneumonia.
    Vardakas KZ; Trigkidis KK; Apiranthiti KN; Falagas ME
    Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 29027205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
    Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial Therapy for Pneumonia in the Emergency Department: The Impact of Clinical Pharmacists on Appropriateness.
    Faine BA; Mohr N; Dietrich J; Meadow L; Harland KK; Chrischilles E
    West J Emerg Med; 2017 Aug; 18(5):856-863. PubMed ID: 28874937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial drug prescribing patterns for community-acquired pneumonia in hospitalized patients: A retrospective pilot study from New Delhi, India.
    Kotwani A; Kumar S; Swain PK; Suri JC; Gaur SN
    Indian J Pharmacol; 2015; 47(4):375-82. PubMed ID: 26288468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study.
    Høgli JU; Garcia BH; Svendsen K; Skogen V; Småbrekke L
    BMC Pulm Med; 2020 Jun; 20(1):169. PubMed ID: 32539706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of the combination and quinolone therapy in community acquired pneumonia].
    Kılıç Soylar Ö; Kılınç O; Ellidokuz H
    Tuberk Toraks; 2015 Sep; 63(3):165-9. PubMed ID: 26523897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of β-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study.
    Ito A; Ishida T; Tachibana H; Nakanishi Y; Tokioka F; Yamazaki A; Washio Y; Irie H; Otake T
    J Infect Chemother; 2021 Oct; 27(10):1447-1453. PubMed ID: 34147355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis.
    Lee JH; Kim HJ; Kim YH
    J Korean Med Sci; 2017 Jan; 32(1):77-84. PubMed ID: 27914135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-Lactam Plus Macrolide for Patients Hospitalized With Community-Acquired Pneumonia: Difference Between Autumn and Spring.
    Kim Y; Jeon Y; Kwon KT; Bae S; Hwang S; Chang HH; Kim SW; Lee WK; Yang KH; Shin JH; Shim EK
    J Korean Med Sci; 2022 Nov; 37(45):e324. PubMed ID: 36413797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An audit and feedback intervention study increased adherence to antibiotic prescribing guidelines at a Norwegian hospital.
    Høgli JU; Garcia BH; Skjold F; Skogen V; Småbrekke L
    BMC Infect Dis; 2016 Feb; 16():96. PubMed ID: 26920549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Effectiveness of First-Line and Alternative Antibiotic Regimens in Hospitalized Patients With Nonsevere Community-Acquired Pneumonia: A Multicenter Retrospective Cohort Study.
    Bai AD; Srivastava S; Wong BKC; Digby GC; Razak F; Verma AA
    Chest; 2024 Jan; 165(1):68-78. PubMed ID: 37574164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.
    Postma DF; Spitoni C; van Werkhoven CH; van Elden LJR; Oosterheert JJ; Bonten MJM
    BMC Infect Dis; 2019 Jan; 19(1):17. PubMed ID: 30612559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis.
    Ott SR; Hauptmeier BM; Ernen C; Lepper PM; Nüesch E; Pletz MW; Hecht J; Welte T; Bauer TT
    Eur Respir J; 2012 Mar; 39(3):611-8. PubMed ID: 21965229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic treatment of moderate-severe community-acquired pneumonia: design and rationale of a multicentre cluster-randomised cross-over trial.
    van Werkhoven CH; Postma DF; Oosterheert JJ; Bonten MJ
    Neth J Med; 2014 Apr; 72(3):170-8. PubMed ID: 24846935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia.
    Donà D; Zingarella S; Gastaldi A; Lundin R; Perilongo G; Frigo AC; Hamdy RF; Zaoutis T; Da Dalt L; Giaquinto C
    PLoS One; 2018; 13(2):e0193581. PubMed ID: 29489898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization.
    Peyrani P; Wiemken TL; Metersky ML; Arnold FW; Mattingly WA; Feldman C; Cavallazzi R; Fernandez-Botran R; Bordon J; Ramirez JA
    Infect Dis (Lond); 2018 Jan; 50(1):13-20. PubMed ID: 28699429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
    Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM
    J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrolides are associated with a better survival rate in patients hospitalized with community-acquired but not healthcare-associated pneumonia.
    McEvoy C; Micek ST; Reichley RM; Kan J; Hoban A; Hoffmann J; Shorr AF; Kollef MH
    Surg Infect (Larchmt); 2014 Jun; 15(3):283-9. PubMed ID: 24801126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy.
    van Werkhoven CH; van de Garde EMW; Oosterheert JJ; Postma DF; Bonten MJM
    Respir Med; 2017 Aug; 129():145-151. PubMed ID: 28732822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.